Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.05.2015 | Case report

Dapsone

Drug hypersensitivity syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Levine DM, et al. Recurrent dapsone hypersensitivity syndrome in an HLAB* 13:01-postive individual with occult mycobacterium marinum infection. Journal of General Internal Medicine 30 (Suppl. 2): S446 abstr. 2195193, Apr 2015. Available from: URL: http://doi.org/10.1007/s11606-015-3271-0 [abstract] - USA Levine DM, et al. Recurrent dapsone hypersensitivity syndrome in an HLAB* 13:01-postive individual with occult mycobacterium marinum infection. Journal of General Internal Medicine 30 (Suppl. 2): S446 abstr. 2195193, Apr 2015. Available from: URL: http://​doi.​org/​10.​1007/​s11606-015-3271-0 [abstract] - USA
Metadaten
Titel
Dapsone
Drug hypersensitivity syndrome: case report
Publikationsdatum
01.05.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-1877-y

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Isoniazid

Case report

Tenofovir

Case report

Adalimumab